New clues to restoring fertility in women with disabling ovary disorder

April 9, 2018 by Liane Topham-Kindley, University of Otago
Credit: CC0 Public Domain

Groundbreaking research out of the University of Otago is showing potential to restore fertility in women suffering polycystic ovary syndrome.

Polycystic ovary syndrome (PCOS) is a major endocrine disorder affecting about one in 10 women of reproductive age globally, and is one of the leading causes of infertility in women. Currently, there is no cure.

The syndrome is a set of symptoms related to elevated levels of androgens (male hormones) in females and includes irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain and patches of thick, darker, velvety skin. It is associated with Type 2 diabetes, obesity, , heart disease, mood and endometrial cancer.

Findings from the research, conducted in a pre-clinical model and just published in the Journal of Clinical Investigation Insight, show that blocking androgen actions could help re-set reproductive function to normal levels by modifying brain circuitry important to fertility.

Associate Professor Rebecca Campbell from the University's Centre for Neuroendocrinology and Department of Physiology, says she and her co-investigators, Ph.D. student Mauro Silva and Assistant Research Fellow Mel Prescott, are excited about their findings which are potentially significant for women suffering from the syndrome.

"Our findings suggest that despite the early development of brain pathology in some forms of , normal reproductive function can potentially be restored in adult women with the disorder through modifying the wiring in the brain," Associate Professor Campbell explains.

There is growing evidence the brain is involved in both the development and pathology of polycystic ovary syndrome. The Otago researchers' earlier work in a preclinical model on the syndrome has identified changes in specific brain circuits that may underlie the disorder.

In this most recent study, Associate Professor Campbell and her team investigated when these circuit abnormalities develop and whether the circuits are "hard-wired" or can be changed by blocking androgen actions once the disorder is established.

"We discovered that brain changes occur prior to the onset of puberty, which is before the syndrome appears, suggesting that the precedes disease development," Associate Professor Campbell says.

"We also discovered that, despite this early 'programming' of neural circuitry, long-term blockade of androgen actions was able to completely restore normal wiring and reproductive cycles."

Associate Professor Campbell says that although the work is still pre-clinical, it gives clues about potentially effective therapies in treating the reproductive pathology of polycystic ovary syndrome in women.

Her research team has established a collaboration with clinicians in Sweden to retrospectively look at the impact of receptor blocker drugs on long-term reproductive outcomes in with the .

Explore further: Hormone's effect on neurons linked to polycystic ovarian syndrome

More information: Mauro S.B. Silva et al. Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS, JCI Insight (2018). DOI: 10.1172/jci.insight.99405

Related Stories

Hormone's effect on neurons linked to polycystic ovarian syndrome

January 13, 2016
University of Otago researchers are part of an international team of scientists who have discovered how anti-Müllerian hormone (AMH) may act in the brain to cause polycystic ovary syndrome (PCOS) symptoms.

Women with polycystic ovary syndrome have double the risk of liver disease

March 28, 2018
Scientists at the University of Birmingham have found that increased male hormones result in women with polycystic ovaries having a two-fold increased risk of developing non-alcoholic fatty liver disease.

Study finds new class of androgens play key role in polycystic ovary syndrome

March 14, 2017
Scientists led by the University of Birmingham have discovered that a new class of male sex hormones known as androgens plays a key role in the development of polycystic ovary syndrome (PCOS).

Guideline urges hormone test for women with unwanted hair

March 30, 2018
(HealthDay)—Women with dark, coarse hair growth on the face, chest or back should be tested for polycystic ovary syndrome and other underlying health problems, a new Endocrine Society guideline says.

PCOS may reduce gut bacteria diversity

January 23, 2018
Women who have a common hormone condition that contributes to infertility and metabolic problems tend to have less diverse gut bacteria than women who do not have the condition, according to a new study published in the Endocrine ...

Asthma is associated with polycystic ovary syndrome and excess weight

April 1, 2016
Among reproductive-age women, polycystic ovary syndrome (PCOS) as well as overweight and obesity are independently linked with asthma, new preliminary research from Australia suggests. The results will be presented in a poster ...

Recommended for you

New study reveals time and day women are most likely to give birth

June 15, 2018
A new study has found that the time and day that women give birth can vary significantly depending on how labour starts and the mode of giving birth.

Blood test for pregnant women can predict premature birth

June 7, 2018
A new blood test for pregnant women detects with 75-80 percent accuracy whether their pregnancies will end in premature birth. The technique can also be used to estimate a fetus's gestational age—or the mother's due date—as ...

Drug combination offers more effective care for patients suffering miscarriage

June 6, 2018
A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage ...

Genes, environment and schizophrenia—new study finds the placenta is the missing link

May 28, 2018
Hiding in plain sight, new research shines a spotlight on the placenta's critical role in the nature versus nurture debate and how it confers risk for schizophrenia and likely other neurodevelopmental disorders including ...

Vendors say pot eases morning sickness. Will baby pay a price?

May 22, 2018
(HealthDay)—Nearly 70 percent of Colorado marijuana dispensaries recommended pot products to manage early pregnancy-related morning sickness, new research reveals.

Pregnancy drug DES might have triggered ADHD in the grandchildren of women who used it

May 21, 2018
A study conducted by researchers at Columbia University's Mailman School of Public Health and Harvard T.H. Chan School of Public Health reported elevated odds for attention deficit hyperactivity disorder (ADHD) in the grandchildren ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.